Related Experiment Video

Updated: Dec 29, 2025

Oct4GiP Reporter Assay to Study Genes that Regulate Mouse Embryonic Stem Cell Maintenance and Self-renewal
08:01

Oct4GiP Reporter Assay to Study Genes that Regulate Mouse Embryonic Stem Cell Maintenance and Self-renewal

Published on: May 30, 2012

10.8K

A glimpse into molecular mechanisms of embryonic stem cells pluripotency: Current status and future perspective

Nazila Fathi Maroufi1,2,3, Kouichi Hasegawa4, Vahid Vahedian5,6

  • 1Stem Cell and Regenerative Medicine Institute, Tabriz University of Medical Sciences, Tabriz, Iran.

Journal of Cellular Physiology
|February 5, 2020
PubMed

Insights

Embryonic stem cells (ESCs) hold therapeutic promise but lose differentiation potential with prolonged expansion. This review explores molecular mechanisms and novel strategies to maintain ESC multipotency for regenerative medicine applications.

Area of Science:

  • Stem cell biology
  • Regenerative medicine
  • Developmental biology

Background:

  • Embryonic stem cells (ESCs) possess multipotency for diverse cell lineages, offering therapeutic potential.
  • Prolonged in vitro and ex-vivo expansion of ESCs leads to loss of multipotency, limiting clinical utility.
  • Understanding the molecular basis of stemness is crucial for maintaining ESC function.

Purpose of the Study:

  • To review molecular pathways involved in preserving ESC multipotency.
  • To highlight novel strategies for maintaining ESC stemness during expansion.
  • To discuss harnessing ESC regenerative potential for clinical applications.

Main Methods:

  • Literature review of recent research on ESCs.
  • Analysis of molecular mechanisms regulating stem cell pluripotency.
  • Discussion of emerging strategies for ESC culture and application.

Main Results:

  • Identified key pathways critical for maintaining ESC multipotency.
  • Summarized innovative approaches to counteract stemness loss during expansion.
  • Emphasized the link between preserved multipotency and enhanced regenerative capacity.

Conclusions:

  • Maintaining ESC multipotency is essential for effective therapeutic applications.
  • Novel strategies show promise in preserving stemness during prolonged culture.
  • Further research into ESC regulation can unlock their full regenerative potential.
Keywords:
embryonic stem cellsnano-based technologiesnetwork of transcription factornoncoding RNAssignaling pathwaysmall molecules

More Related Videos

A Simple Method to Identify Kinases That Regulate Embryonic Stem Cell Pluripotency by High-throughput Inhibitor Screening07:18

A Simple Method to Identify Kinases That Regulate Embryonic Stem Cell Pluripotency by High-throughput Inhibitor Screening

Published on: May 12, 2017

6.8K
Kinetic Measurement and Real Time Visualization of Somatic Reprogramming08:56

Kinetic Measurement and Real Time Visualization of Somatic Reprogramming

Published on: July 30, 2016

6.9K

Related Concept Videos

Maintenance of the ES Cell State01:14

Maintenance of the ES Cell State

The cells of the blastocyst inner cell mass only remain pluripotent for a short time. This state of pluripotency and self-renewal can be maintained in embryonic stem (ES) cell culture by adding specific chemicals or growth factors to ensure the cells can continue dividing and later differentiate into different cell types. In some cases, the cells are grown on a feeder layer of differentiated cells, which provides the growth factors and extracellular matrix components necessary for stem cell...
2.6K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
5.2K
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
27.1K
Embryonic Stem Cells00:58

Embryonic Stem Cells

Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.
32.0K
Embryonic Stem Cells00:57

Embryonic Stem Cells

Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
4.5K
Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.5K